Stéphane Plaisance
Impact in
- Cancer Research top 1%
- NF-κB Signaling Pathways
- Cancer, Hypoxia, and Metabolism
- Immunology top 1%
- Immune Response and Inflammation
- Phagocytosis and Immune Regulation
- Complement system in diseases
Papers in
- Immunology 26
- Immunotherapy and Immune Responses 8
- Immune Response and Inflammation 7
- T-cell and B-cell Immunology 5
- Phagocytosis and Immune Regulation 5
- Co-authors
- Guy Haegeman (7 shared papers)Wim Vanden Berghe (6 shared papers)Karolien De Bosscher (4 shared papers)Elke Boone (5 shared papers)Walter Fiers (4 shared papers)M. Lienhard Schmitz (2 shared papers)Peter Carmeliet (10 shared papers)Mieke Dewerchin (6 shared papers)
- Journals
- Blood (5 papers)The EMBO Journal (3 papers)Journal of Clinical Investigation (3 papers)Journal of Biological Chemistry (3 papers)International Immunology (2 papers)
- Partner nations
- BelgiumFranceUnited States
In The Last Decade
Stéphane Plaisance
47 papers receiving 5.9k citations
Stéphane Plaisance's Hit Papers
Peers
Comparison fields: 5 of 134
- Cancer Research 1.4k
- Immunology 2.0k
- Oncology 1.1k
- Molecular Biology 2.7k
- Hematology 416
Countries citing papers authored by Stéphane Plaisance
This map shows the geographic impact of Stéphane Plaisance's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stéphane Plaisance with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stéphane Plaisance more than expected).
Fields of papers citing papers by Stéphane Plaisance
This network shows the impact of papers produced by Stéphane Plaisance. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stéphane Plaisance. The network helps show where Stéphane Plaisance may publish in the future.
Co-authors
The 25 scholars most cited alongside Stéphane Plaisance, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | p38 and Extracellular Signal-regulated Kinase Mitogen-activated Protein Kinase Pathways Are Required for Nuclear Factor-κB p65 Transactivation Mediated by Tumor Necrosis Factor Hit paper breakdown → | 1998 | 640 |
| 2 | Anti-PlGF Inhibits Growth of VEGF(R)-Inhibitor-Resistant Tumors without Affecting Healthy Vessels Hit paper breakdown → | 2007 | 634 |
| 3 | Loss of HIF-2α and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice Hit paper breakdown → | 2002 | 589 |
| 4 | The p38/RK mitogen‐activated protein kinase pathway regulates interleukin‐6 synthesis response to tumor necrosis factor. Hit paper breakdown → | 1996 | 579 |
| 5 | 2009 | 410 | |
| 6 | Genome dynamics of the human embryonic kidney 293 lineage in response to cell biology manipulations Hit paper breakdown → | 2014 | 400 |
| 7 | 1997 | 315 | |
| 8 | 1999 | 306 | |
| 9 | 1999 | 282 | |
| 10 | 2000 | 276 | |
| 11 | 2005 | 203 | |
| 12 | 2012 | 173 | |
| 13 | 2009 | 138 | |
| 14 | 1997 | 133 | |
| 15 | 2006 | 118 | |
| 16 | 2008 | 74 | |
| 17 | Receptors for interleukin 2 on human squamous cell carcinoma cell lines and tumor in situ. | 1992 | 71 |
| 18 | 2020 | 45 | |
| 19 | 2008 | 44 | |
| 20 | 1998 | 43 |
About Stéphane Plaisance
Stéphane Plaisance is a scholar working on Immunology, Molecular Biology, Oncology, Cancer Research and Physiology, having authored 48 papers that have together received 6.0k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (8 papers), Cytokine Signaling Pathways and Interactions (7 papers), Immune Response and Inflammation (7 papers), NF-κB Signaling Pathways (6 papers), Erythrocyte Function and Pathophysiology (5 papers), T-cell and B-cell Immunology (5 papers), Cell Adhesion Molecules Research (5 papers) and Phagocytosis and Immune Regulation (5 papers). The work is most often cited by research in Cancer Research (1.4k citations), Immunology (2.0k citations), Oncology (1.1k citations), Molecular Biology (2.7k citations) and Hematology (416 citations). Stéphane Plaisance has collaborated with scholars based in Belgium, France and United States. Frequent co-authors include Guy Haegeman, Wim Vanden Berghe, Karolien De Bosscher, Elke Boone, Walter Fiers, M. Lienhard Schmitz, Peter Carmeliet, Mieke Dewerchin, Lieve Moons and Rudi Beyaert. Their work appears in journals such as Blood, The EMBO Journal, Journal of Clinical Investigation, Journal of Biological Chemistry and International Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.